TADA3 and ovarian cancer: Notably, it has previously been reported that autoantibodies against RALBP1, transcriptional adapter 3 (TALD3L), E3 ubiquitin–protein ligase CBL-B (CBLB) and serine/arginine-rich splicing factor 10 (FUSIP1) are statistically significantly elevated in sera of ovarian cancer patients in comparison to healthy controls [10].